Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Qiagen NV    QGEN   NL0000240000

QIAGEN NV (QGEN)

Delayed Quote. Delayed  - 06/27 10:00:00 pm
20.19 USD   -3.90%
06/23 QIAGEN NV : Announces Successful Completion of Tender Offer for Shar..
06/21 QIAGEN NV : Joins Consortium to Map Microbial Genomes in 54 Cities
06/21 QIAGEN NV : joins consortium to map microbial genomes in 54 cities
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3061 3451 2811 3321 4161 511
Operating income (EBITDA)404394467416453484
Operating profit (EBIT)318313315303331370
Pre-Tax Profit (EBT)37,3-----
Net income69,1117127151192227
P/E ratio82,148,951,236,929,522,4
EPS ( $ )0,290,480,540,570,710,94
Dividend per Share ( $ )-----0,13
Yield-----0,61%
Reference price ( $ )23.8123.4627.6521.0121.0121.01
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt46559563944318148,5
Finance------
Operating income (EBITDA)404394467416453484
Leverage
(Debt/EBITDA)
1,15x1,51x1,37x1,06x0,40x0,10x
Capital Expenditure84,586,697,8101107110
Book Value Per Share (BVPS)11,6 $11,4 $11,0 $11,7 $12,5 $13,5 $
Cash Flow per Share1,07 $1,19 $1,34 $1,57 $1,69 $1,82 $
Announcement Date01/29/2014
06:00am
01/29/2015
03:06pm
02/02/2016
11:46pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 036 M$ -
Entreprise Value (EV) 5 479 M$ 5 218 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 36,9x 29,5x
Capitalization / Revenue 3,78x 3,56x
EV / Revenue 4,11x 3,68x
EV / EBITDA 13,2x 11,5x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,79x 1,68x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,7% 23,4%
operating Leverage (Delta EBIT / Delta Sales) - 1,47x
Net Margin (Net Profit / Revenue) 11,4% 13,6%
ROA (Net Profit / Asset) 5,11% 5,61%
ROE (Net Profit / Equities) 8,48% 8,78%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,55% 7,57%
Cash Flow / Sales 27,5% 27,9%
Capital Intensity (Assets / Sales) 2,22x 2,42x
Financial Leverage (Net Debt / EBITDA) 1,06x 0,40x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend